(Q35826128)

10 August 2017

Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers (English)

1 reference

10 August 2017

1 reference

Teng C Hua

1

1 reference

10 August 2017

Alan Pan

2

1 reference

10 August 2017

Clark Chan

3

1 reference

10 August 2017

Yeo K Poo

4

1 reference

10 August 2017

Michael H Skinner

5

1 reference

10 August 2017

Mary P Knadler

6

1 reference

10 August 2017

Celedon R Gonzales

7

1 reference

10 August 2017

Stephen D Wise

8

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

57

1 reference

10 August 2017

5

1 reference

10 August 2017

652-656

1 reference

Fluoxetine inhibits the metabolism of tolterodine-pharmacokinetic implications and proposed clinical relevance

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884503

LY248686, a new inhibitor of serotonin and norepinephrine uptake.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884503

Duloxetine versus placebo in the treatment of stress urinary incontinence

11 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02068.X

Which women with stress incontinence require urodynamic evaluation?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02068.X

Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02068.X

Duloxetine for the treatment of major depressive disorder.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884503

Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884503

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15089819

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15089819

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2004.02068.X

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

15089819

1 reference